Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial.

Palich R, Ghosn J, Chaillon A, Boilet V, Nere ML, Chaix ML, Delobel P, Molina JM, Lucht F, Bouchaud O, Rieux V, Thiebaut R, Levy Y, Delaugerre C, Lelievre JD; VRI02/ANRS149 LIGHT Vaccine Trial Group.

AIDS. 2019 Feb 1;33(2):279-284. doi: 10.1097/QAD.0000000000002058.

PMID:
30325777
2.

Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design.

Richert L, Doussau A, Lelièvre JD, Arnold V, Rieux V, Bouakane A, Lévy Y, Chêne G, Thiébaut R; Vaccine Research Institute (VRI).

Trials. 2014 Feb 26;15:68. doi: 10.1186/1745-6215-15-68.

3.

Amoxicillin is effective against penicillin-resistant Streptococcus pneumoniae strains in a mouse pneumonia model simulating human pharmacokinetics.

Abgueguen P, Azoulay-Dupuis E, Noel V, Moine P, Rieux V, Fantin B, Bedos JP.

Antimicrob Agents Chemother. 2007 Jan;51(1):208-14. Epub 2006 Oct 23.

4.

The human immunodeficiency virus preventive vaccine research at the French National Agency for acquired immunodeficiency syndrome research.

Fischer E, Rieux V, Guillet JG, Kazatchkine M.

Mem Inst Oswaldo Cruz. 2005 Feb;100(1):79-84. Epub 2005 Apr 12.

5.

Activities of garenoxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model.

Azoulay-Dupuis E, Bédos JP, Mohler J, Peytavin G, Isturiz R, Moine P, Rieux V, Cherbuliez C, Péchère JC, Fantin B, Köhler T.

Antimicrob Agents Chemother. 2004 Mar;48(3):765-73.

6.

Streptococcus pneumoniae strain-dependent lung inflammatory responses in a murine model of pneumococcal pneumonia.

Mohler J, Azoulay-Dupuis E, Amory-Rivier C, Mazoit JX, Bédos JP, Rieux V, Moine P.

Intensive Care Med. 2003 May;29(5):808-16. Epub 2003 Mar 29.

PMID:
12665994
7.

Complex relationship between acquisition of beta-lactam resistance and loss of virulence in Streptococcus pneumoniae.

Rieux V, Carbon C, Azoulay-Dupuis E.

J Infect Dis. 2001 Jul 1;184(1):66-72. Epub 2001 Jun 8.

PMID:
11398111
8.

Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice.

Azoulay-Dupuis E, Rieux V, Muffat-Joly M, Bédos JP, Vallée E, Rivier C, Isturiz R, Carbon C, Moine P.

Antimicrob Agents Chemother. 2000 Jun;44(6):1575-7.

9.

[Selection of virulent mutants of Streptococcus pneumoniae. Utilization of a murine model of septicemia].

Amory-Rivier C, Rieux V, Azoulay-Dupuis E, Carbon C, Trombe MC.

Pathol Biol (Paris). 1999 May;47(5):519-25. French.

PMID:
10418032
10.
11.

Efficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model.

Bédos JP, Rieux V, Bauchet J, Muffat-Joly M, Carbon C, Azoulay-Dupuis E.

Antimicrob Agents Chemother. 1998 Apr;42(4):862-7.

12.

Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae.

Sauve C, Azoulay-Dupuis E, Moine P, Darras-Joly C, Rieux V, Carbon C, Bédos JP.

Antimicrob Agents Chemother. 1996 Dec;40(12):2829-34.

14.

Supplemental Content

Support Center